Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026
-
DarkIris Inc. Announces Share Consolidation
-
Micron to Host Technology Webinar on Oct. 21
-
Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.
-
Hyperion DeFi Schedules Third Quarter Earnings Call for Thursday, November 12 at 8:00 a.m. ET
-
Medera's Novoheart Technology Powers Advanced Human Cardiac Disease Modeling at Singapore's New CIPHER Research Centre
-
Super League Stockholders Approve All Proposals Related to Metaplanet's Proposed 2,100 Bitcoin and Cash Investment
-
Immutep Announces Late-Breaking Abstract on IMP761 Accepted for Poster Presentation at ACR Convergence 2026
-
Stingray Unveils Ford Streaming Radio and Lincoln Streaming Radio Apps to Enhance the In-Vehicle Audio Experience
-
Stratum Holdings Corp. Announces Letter of Intent for Proposed Sale of Legacy Real Estate Businesses, Accelerating Pivot to AI Infrastructure and GPU Leasing
-
DFDV Continues Accumulating SOL Ahead of Solana’s Alpenglow Upgrade
-
Rivus Pharmaceuticals to Present Preclinical Obesity Data for Muscle-Preserving, Oral GLP-1 RV-8451 at ObesityWeek®
-
Aqua Finance Names Michelle Gill as Chief Executive Officer
-
SCOKC Upgrades Its 10×32 and 12×32 Monoculars and Introduces a New 8×32 Model for Outdoor Exploration
-
Nextiva Selects Intrado NG Nexus™ to Advance NG9-1-1 Compliance Readiness
-
OFA Group Enters Public-Private Sounding Survey for 3.71-Hectare Naarai Port Green Space, Expanding Its Development Footprint in Choshi
-
ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026
-
U.S. DOT Revocation of Restrictions Affecting Mexico-U.S. Service
-
Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026
-
UroGen Announces FDA Acceptance of the New Drug Application for UGN-103, an Investigational Treatment for Adults with Recurrent LG-IR-NMIBC
-
Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026
-
Kawasaki Engines Celebrates 'No Crew Like You' Theme And Community Impact at Equip Expo 2026
-
Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology
-
Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026
-
Traction Uranium Completes Initial Drilling at the Aurora Project
-
ASML reports transactions under its current share buyback program
-
STMicroelectronics announces status of common share repurchase program
-
Indian Lab Sthānika’s AI Model Takes Second Place on Jev Decision Index
-
Novo Nordisk A/S - share repurchase programme
-
3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finland
-
Transactions in connection with share buy-back program
-
Golar LNG Limited – Q3 2026 results presentation
-
Athene Announces Third Quarter 2026 Fixed Income Investor Call
-
Miracles Surpasses 100,000 Personalized Children's Books, Now Printed in the USA for American Families
-
Ritedose Partners with Newberry College to Launch Leadership Development Program
-
Allied Announces Appointment of Donald Clow to the Board of Trustees and Board Committee Chair Changes
-
Third Partners Launches 3P/AI as Lean Sustainability Teams Face California’s Nov. 10 Deadline
-
Percussion drilling program under way at Leviathan Metals’ Serule and Foley Uranium Projects, Botswana
-
Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases
-
BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group
-
DEEP SEA MINERALS CORP. HIGHLIGHTS U.S. TREASURY RECOGNITION OF DEEP SEA MINING IN CRITICAL MINERALS POLICY AND PROVIDES CORPORATE UPDATE
-
Cytokinetics Announces Health Canada Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
-
Papa Johns Summons a Halloween Favourite: The Jack-o’-Lantern Pizza Returns
-
NXGen Brands Announces Completed BLAQclouds Control Acquisition and Zero Outstanding Debt
-
Duchess Restaurants Selects Beyond Oil as Frying Standard Across the Chain
-
SL Green Refinances 245 Park Avenue for $2.0 Billion
-
Caliber CEO Chris Loeffler to Speak on Public Companies & Crypto Panel at Tokenize! Las Vegas 2026
-
Glass House Brands Reports Preliminary Unaudited Third Quarter Financial Results and Resignation of John Nichols Jr. from Board of Directors
-
REPEAT - Cambria Gold Mines Intersects 98.56 g/t Gold over 8.2 Metres at the Silver Coin Deposit, Premier Gold Project
-
Chase Bell and Lira Bring Their “Do Me” Collaboration to Hollywood in a Sold-Out Performance at East West Studios
